Cover Image

Cost-utility of Protocols of BFM-ALL and UK-ALL for Treatment of Children with Acute Lymphoblastic Leukemia in Iran

Background: There is a requirement to assess the effectiveness and resources used in two protocols United Kingdom (UK-ALL) and Berlin-Frankfurt-Munster (BFM-ALL) that are most commonly used to treatment of ALL patients by oncologists in Iran. Accordingly, we analyzed the cost of treatment and utilit...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hadi HAYATI (Author), Abbas KEBRIAEEZADEH (Author), Mohammad Ali EHSANI (Author), Shekoufeh NIKFAR (Author), Ali AKBARI SARI (Author), Azim MEHRVAR (Author), Elham SHAHGHOLI (Author)
Format:	Book
Published:	Tehran University of Medical Sciences, 2018-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dermatological toxicity of acute lymphoblastic leukemia treatment by protocol ALL IC-BFM 2002
by: Timur T. Valiev, et al.
Published: (2022)

Quality of life in children with acute lymphoblastic leukemia under chemotherapy: A review
by: Hadi Hayati, et al.
Published: (2018)

Success of induction therapy in acute lymphoblastic leukemia (ALL) in children as per modified BFM-2002 in a tertiary care government hospital
by: Kaushambi Basu, et al.
Published: (2017)

Cost-Effectiveness of the treatment protocols of pediatrics with ‎Acute ‎Lymphoblastic Leukemia (Decision tree modelling)
by: Hadi Hayati, et al.
Published: (2024)

3-year survival rate in acute lymphoblastic leukemia: comparison of ALL-2006 and ALL-2013 Protocols
by: Avyandita Meirizkia, et al.
Published: (2021)

ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol
by: Yu Wang, et al.
Published: (2018)

Treatment of pediatric acute lymphoblastic leukemia in India on BFM 95 protocol backbone with relevant modifications and minimal residual disease application - Doable and effective
by: Dhwanee Thakkar, et al.
Published: (2022)

Prevalence of osteonecrosis in survivors of childhood acute lymphoblastic leukaemia of Indian ethnicity treated with BFM protocol
by: Sanjeev Khera, et al.
Published: (2024)

Shorter maintenance therapy in childhood Acute Lymphoblastic Leukemia. The experience of the prospective, randomized Brazilian GBTLI ALL-93 protocol.
by: Silvia Regina Brandalise, et al.
Published: (2016)

Treatment methods for patients suffering from acute lymphoblastic leukemia (all) - a brief review
by: Zuzanna Czudy, et al.
Published: (2023)

Costs associated with adverse events from remission induction for children with Acute Lymphoblastic Leukemia (ALL)
by: Eréndira Mejía-Aranguré, et al.
Published: (2022)

Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran
by: Abdollahi Mohammad, et al.
Published: (2005)

Expression pattern of CD179 in b-cell acute lymphoblastic leukemia (B-All): A potential utility for lineage assignment and B-ALL MRD monitoring
by: Tembhare Prashant, et al.
Published: (2022)

Erdheim-Chester disease in a case of B cell acute lymphoblastic leukemia (infant all) : Uncommon presentation
by: Amit. D. Galgali, et al.
Published: (2022)

Fate of children after the first relapse of acute lymphoblastic leukemia: InPOG-ALL-19-02 study
by: Pritam Singha Roy, et al.
Published: (2024)

The Functional Role of PRC2 in Early T-cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) - Mechanisms and Opportunities.
by: Kathrin Maria Bernt, et al.
Published: (2016)

Fatigue Management Through Aerobic Physical Exercise in Children with Acute Lymphoblastic Leukemia (ALL) : A Literature Review
by: Ikeu Nurhidayah, et al.
Published: (2022)

Treatment of newly diagnosed paediatric acute Lymphoblastic leukaemia on BFM- based chemotherapy protocol & feasibility and outcome from a tertiary care center in India
by: Vipin Khandelwal, et al.
Published: (2024)

Treatment of newly diagnosed paediatric acute lymphoblastic leukaemia on BFM-based chemotherapy protocol: Feasibility and outcome from a tertiary care center in India
by: Vipin Khandelwal, et al.
Published: (2023)

Clinical profile and outcome of early T-precursor (ETP) acute lymphoblastic leukemia (ALL) in a tertiary care cancer centre
by: Cheriyalinkal Parambil Badira, et al.
Published: (2016)

Treatment of acute lymphoblastic leukemia with protocol Hongkong-Indonesia Acute Lymphoblastic Leukemia 97
by: Johannes Bondan Lukito
Published: (2007)

Acute lymphoblastic leukemia (ALL) with KMT2A gene rearrangement in infants - characteristic clinical picture based on a case report
by: Maria Kowalczuk, et al.
Published: (2022)

Digital India for pediatric acute lymphoblastic leukemia (ALL): Tracking reports during maintenance phase using a web-based application
by: Subham Kumar, et al.
Published: (2024)

A mouse model for inducible overexpression of Prdm14 results in rapid-onset and highly penetrant T-cell acute lymphoblastic leukemia (T-ALL)
by: Brandi L. Carofino, et al.
Published: (2013)

The Effectiveness of Fulvestrant in postmenopausal advanced breast cancer; systematic review of clinical evidence
by: Amir Hashemi-Meshkini, et al.
Published: (2015)

Cost analysis of childhood asthma in Iran: A cost evaluation based on referral center data for asthma and allergies
by: Mohammad Ali Rezvanfar, et al.
Published: (2013)

TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial
by: Irene L. M. Klaassen, et al.
Published: (2017)

Brainy surprises: 12 years of acute central nervous system(CNS) events in pediatric acute lymphoblastic leukemia (ALL) -A single center's story
by: Somdipa Pal, et al.
Published: (2024)

Primary familial intrahepatic cholestasis in a child with acute lymphoblastic leukemia: A case report and review of literature of acute liver failure in all patients
by: Vagisha Sharma, et al.
Published: (2022)

The effect of resveratrol on the expression of MDR1 gene in leukemic lymphoblast's of acute lymphoblastic leukemia patients
by: Abbasali Hoseinpoor feyzi, et al.
Published: (2015)

Risk Factors of Supply Chain in Biopharmaceutical Companies in Iran
by: Hadi Abbasian, et al.
Published: (2021)

Acute Lymphoblastic Leukemia in Children
by: Dhanu Ganesh Rao, et al.
Published: (2013)

Acute Lymphoblastic Leukemia and Seizures
by: J Gordon Millichap
Published: (1995)

Acute lymphoblastic leukemia in adults
by: Josep-Maria Ribera
Published: (2011)

Effect of Taurine on Febrile Episodes in Acute Lymphoblastic Leukemia
by: Mina Islambulchilar, et al.
Published: (2015)

Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
by: Luke Maese, et al.
Published: (2022)

Expression Profile of LncRNAs in Childhood Acute Lymphoblastic Leukemia: A Pilot Study
by: Zohreh Mousavi, et al.
Published: (2021)

Characterization of Acute Lymphoblastic Leukemia Subtypes in Moroccan Children
by: Fatima Bachir, et al.
Published: (2009)

Evaluation of Methylation at Promoter Regions of Long Non-coding RNAs in Patients with Acute Lymphoblastic Leukemia
by: Zohreh Mousavi, et al.
Published: (2021)

CNS complications during treatment of acute lymphoblastic leukemia/lymphoblastic lymphoma
by: Piali Mandal, et al.
Published: (2016)